Sort
3,198 grants matching “mrna vaccine”
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$613,686Norbert Pardi · University Of Pennsylvania · R01 · FY2023 · AI
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$613,686Norbert Pardi · University Of Pennsylvania · R01 · FY2022 · AI
SARS-CoV-2 Vaccine Responses in children with genetic or acquired B cell deficiencies
$613,169Wen-Yuan E Hsieh · University Of Colorado Denver · R01 · FY2023 · AI
Porous silicon microparticle-based subunit vaccines for SARS-CoV-2
$613,059Tian Wang · University Of Texas Med Br Galveston · R01 · FY2023 · AI
Strategies for Cancer Vaccine Development: Preclinical Studies
$612,693Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
COVID vaccine-associated allergic reactions
$612,630Pamela Frischmeyer-Guerrerio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Development of novel HIV Env vaccines to augment B lymphocyte responses via delivery of stabilized well-ordered Env spikes for comparative evaluation in preclinical immunogenicity and efficacy studies
$611,410Christopher Parks · International Aids Vaccine Initiative · P01 · FY2018 · AI
Interactions of Retroviral Proteins with Nucleic Acids
$610,882Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
The impact of T cell selection on vaccine durability
$610,852Laura Su · University Of Pennsylvania · R01 · FY2025 · AI
The impact of T cell selection on vaccine durability
$610,852Laura Su · University Of Pennsylvania · R01 · FY2024 · AI
Fox COBRE Phase II Admin Core
$610,481Joseph M Fox · University Of Delaware · P20 · FY2021 · GM
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$610,421Norbert Pardi · University Of Pennsylvania · R01 · FY2021 · AI
The connection of innate and adaptive anti-cancer immunity
$610,288John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Defining molecular mechanisms of combination adjuvants: a systems immunology, transcriptomics and imaging approach
$610,134David Huw Davies · University Of California-Irvine · U01 · FY2021 · AI
Development of Universal Influenza Virus Vaccines Using Nucleoside-Modified Messenger RNA
$609,757Norbert Pardi · University Of Pennsylvania · R01 · FY2020 · AI
Multiplex Next Generation Sequencing of Glycans and Nucleic Acids for Accelerating the Development of Cell Factories and Bioprocesses for Glycoprotein Biomanufacturing
$609,503Nathan E Lewis · University Of California-San Diego · · FY2024 · ENG
Murine Memory B Cell Development and Function
$609,229Mark J Shlomchik · University Of Pittsburgh At Pittsburgh · R56 · FY2016 · AI
Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2
$608,161Yogesh K Gupta · University Of Texas Hlth Science Center · R01 · FY2021 · AI
Immune cell control of ovarian cancer
$605,550Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$605,248Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2012 · DK
Poxvirus Gene Expression
$605,159Bernard Moss · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Human Papillomavirus Infection in Perinatally HIV-infected Adolescents in Asia
$605,087Annette H Sohn · Foundation For Aids Research · R01 · FY2013 · HD
SARS-CoV-2 Vaccine Responses in children with genetic or acquired B cell deficiencies
$604,346Wen-Yuan E Hsieh · University Of Colorado Denver · R01 · FY2025 · AI
SARS-CoV-2 Vaccine Responses in children with genetic or acquired B cell deficiencies
$604,346Wen-Yuan E Hsieh · University Of Colorado Denver · R01 · FY2024 · AI
Immune cell control of ovarian cancer
$603,049Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA